The purpose of this study is to evaluate product performance of Magnetic Resonance (MR) Conditional Cardiac Implantable Electronic Devices (CIED) following 3 tesla (3T) MRI exposure. This will be achieved by evaluating the changes in pacing capture threshold (PCT) measurements following 3T MRI scan exposure. This study is required by FDA as a condition of approval of 3T MRI compatible labeling of applicable CIED systems. This study is conducted within Medtronic's post-market surveillance platform, the Product Surveillance Registry (PSR).
Study Type
OBSERVATIONAL
Enrollment
41
The proportion of patients implanted with an MR Conditional CIED System with a pre-MRI to post-MRI scan PCT measure change of >0.5 Volts following 3T MRI scan exposure.
Time frame: Patients will be followed for approximately 5 years.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Birmingham, Alabama, United States
Unnamed facility
Anchorage, Alaska, United States
Unnamed facility
Chandler, Arizona, United States
Unnamed facility
Jonesboro, Arkansas, United States
Unnamed facility
Little Rock, Arkansas, United States
Unnamed facility
Bakersfield, California, United States
Unnamed facility
Chula Vista, California, United States
Unnamed facility
La Quinta, California, United States
Unnamed facility
Los Angeles, California, United States
Unnamed facility
Palm Springs, California, United States
...and 194 more locations